Motivational interviewing to improve insight and treatment adherence in schizophrenia

Psychiatric Rehabilitation Journal

Volumn 26, Issue 1, 2002, Pages 23-32

  Rüsch, Nicolas ^a   Corrigan, Patrick W ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

CLINICAL TRIAL; COGNITIVE DEFECT; COPING BEHAVIOR; HEALTH BEHAVIOR; HUMAN; INTERVIEW; MENTAL DISEASE; MOTIVATION; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRESCRIPTION; PSYCHOTHERAPY; REVIEW; SCHIZOPHRENIA; TREATMENT OUTCOME; ADAPTIVE BEHAVIOR; ARTICLE; ATTITUDE TO HEALTH; PSYCHOLOGIC TEST; PSYCHOLOGY;

ADAPTATION, PSYCHOLOGICAL; ATTITUDE TO HEALTH; HEALTH BEHAVIOR; HUMANS; INTERVIEW, PSYCHOLOGICAL; MOTIVATION; PATIENT COMPLIANCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0036024001     PISSN: 1095158X     EISSN: None     Source Type: Journal    
DOI: 10.2975/26.2002.23.32     Document Type: Review

References (90)

1. Insight and paranoid disorders in late life
2. Awareness of illness in schizophrenia and schizoaffective and mood disorders
3. The assessment of insight: A methodological review
4. Poor insight in schizophrenia
5. Assessment of insight in psychosis
6. Awareness of illness in schizophrenia
7. Factors influencing relapse in the long-term course of schizophrenia
8. Contribution à l'étude des troubles mentaux dans l'hemiplégie organique cérébrale (anosognosie)
9. Treating substance abuse among patients with schizophrenia
10. Correlates of insight and insight change in schizophrenia
11. Referral failures: A one-year follow-up
12. Noncompliance in community psychiatry: A review of clinical interventions
13. Insight, neurocognitive function and symptom clusters in chronic schizophrenia
14. Adherence to anti-psychotic medications and health behavior theories
15. From noncompliance to collaboration in the treatment of schizophrenia
16. Motivational interviews as goal assessment for persons with psychiatric disability
17. Is poor insight in psychotic disorders associated with poor performance on the Wisconsin Card Sorting Test?
18. Psychopathological dimensions and lack of insight in schizophrenia
19. Awareness of illness in schizophrenia and outpatient treatment adherence
20. Insight and psychosis
21. Insight and psychotic illness. Cross-sectional and longitudinal associations
22. Teaching the client with schizophrenia about medication
23. Insight in paranoid schizophrenia. Its relationship to psychopathology and premorbid adjustment
24. Changing addictive behaviors: A process perspective
25. Self-efficacy and the stages of self-change of smoking
26. The contribution of depression and denial towards understanding the unawareness of symptoms in schizophrenic out-patients
27. Social skills training of out-patient groups. A controlled study of rehearsal and homework
28. Insight in first-admission psychotic patients
29. Misconceptions about the Fishbein model: Reflections on a study by Songer-Nocks
30. Smaller brain size associated with unawareness of illness in patients with schizophrenia
31. Cognitive-behavioral therapy for medication resistent symptoms
32. Lack of insight in psychotic and affective disorders: A review of empirical studies
33. Neurocognitive deficits in schizophrenia
34. What are the functional consequences of neurocognitive deficits in schizophrenia?
35. Relative efficacy of modeling and instructions in eliciting social behavior from chronic psychiatric patients
36. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia
37. Insight and psychosis: A social perspective
38. Compliance in the long-term treatment of schizophrenia
39. The positive and negative syndrome scale (PANSS) for schizophrenia
40. Utility of the health belief model in examining medication compliance among psychiatric outpatients
41. Psychological predictors of insight and compliance in psychotic patients
42. Compliance therapy in psychotic patients: Randomised controlled trial
43. Randomised controlled trial of compliance therapy. 18-month follow-up
44. Insight and clinical correlates in schizophrenia
45. Insight and adherence to medication in chronic schizophrenics
46. Labeling and stigma
47. Work rehabilitation and improvements in insight in schizophrenia
48. Insight and psychosocial treatment compliance in schizophrenia
49. Insight in clinical psychiatry revisited
50. A controlled evaluation of systematic desensitisation and social skills training for socially inadequate psychiatric patients
51. Über die Stellungnahme zur abgelaufenen akuten Psychose
52. Insight in schizophrenia. Its relationship to acute psychopathology
53. Insight and the clinical outcome of schizophrenic patients
54. Common sense, insight, and neuropsychological test performance in schizophrenia patients
55. Integration and sealing over. Clinically distinct recovery styles from schizophrenia
56. Unawareness of deficits in neuropsychological syndromes
57. The neuropsychology of insight: Impaired awareness of deficits in a psychiatric context
58. Insight in schizophrenia and mood disorders and its relation to psychopathology
59. Motivational interviewing: Research, practice, and puzzles
60. Insight in schizophrenia: Its relationship to measures of executive functions
61. Effects of social skills training groups and sensitivity training groups with psychiatric patients
62. Unawareness of illness and its relationship with depression and self-deception in schizophrenia
63. Comorbidity of schizophrenia and substance abuse: Implications for treatment
64. Effects of clozapine on awareness of illness and cognition in schizophrenia
65. Lack of insight: Its status within schizophrenic psychopathology
66. Beyond rational choice: The social dynamics of how people seek help
67. In search of how people change: Applications to addictive behaviors
68. Insight and hospital adjustment
69. What is motivational interviewing?
70. Patients' compliance with health regimens
71. A comparative study of insight scales and their relationship to psychopathological and clinical variables
72. Cognitive disorders and negative symptoms as correlates of motivational deficits in psychotic patients
73. Insight and illness in chronic schizophrenia
74. Symptomatology and insight in schizophrenia
75. The relationship between insight, illness and treatment outcome in schizophrenia
76. Does insight affect long-term impatient treatment outcome in chronic schizophrenia?
77. The relative influences of symptoms, insight, and neurocognition on social adjustment in schizophrenia and schizoaffective disorder
78. Outcome and efficacy expectancy in the prediction of post-treatment drinking behaviour
79. Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients
80. Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia
81. A group social skills training program with psychiatric patients: Outcome, drop-out rate and prediction
82. Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: A magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins
83. Psychiatric new-patient clinic non-attenders
84. Cognitive modifiability as a measure of readiness for rehabilitation
85. Unawareness of illness and neuropsychological performance in chronic schizophrenia
86. Further parameters of insight and neuropsychological deficit in schizophrenia and other chronic mental disease